SELTASQUARE
LIVE

Serial Number

79448989

Owner

SELTA SQUARE Inc.

Filing Date

Jan 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SELTASQUARE Trademark

Serial Number: 79448989

SELTASQUARE is a trademark filed by SELTA SQUARE Inc. on January 30, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SELTA SQUARE Inc. (2 trademarks)

C-19, #804, 8th Floor, 124, Unjung-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13466 , KR

Entity Type: 99

Trademark Details

Filing Date

January 30, 2026

Registration Date

Not Registered

Goods & Services

Development of computer software for clinical big data processing; research and development of technology for biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer programming in the medical field; providing computer software technical support services in the field of medical diagnostics; computer programming services for remote management of medical diagnostic device; providing information on the testing inspection and research of medical products; consultancy in the field of testing inspection research of medical products; clinical trials; clinical research in the field of medicine.

Pharmacovigilance professional education; medicinal products clinical trial professional education; educational services relating to medical and drug preparation.

Software for detecting, evaluating, analyzing, monitoring, processing, reporting, managing clinical data related to medicine; software for detecting, evaluating, analyzing, monitoring, processing, reporting, managing post-marketing clinical data of medicine; software for tracking, evaluating, analyzing, monitoring, processing, reporting, managing drug safety using clinical data; pharmacovigilance software using clinical data; software for detecting, evaluating, analyzing, monitoring, processing, interpreting, reporting, managing, preventing adverse effect or side effect of medicine using clinical data.

Medical and health care services; collection examination analysis and reporting relating to clinical data; provision of medical information; providing information in the field of medicine; providing medical information based on clinical data; clinical pathology examination.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2026 CNRT
ASSIGNED TO EXAMINER
May 28, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
May 1, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2026 REPR